Telomir Pharmaceuticals, Inc. Common Stock (TELO) quarterly income statement — complete revenue, gross profit & net income history
Telomir Pharmaceuticals, Inc. Common Stock (TELO) annual income statement — 5-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q1'22 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 745.2K | 1.76M | 1.04M | 2.13M | 1.15M | 5.07M | 2.19M | 2.91M | 6.01M | 1.47M | 1.92M | 1.08M | 954.15K | 1.43M | 482.94K | 487.1K | 63.49K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 493.31K | 1.32M | 573.54K | 838.47K | 386.95K | 5.03M | 1.85M | 2.64M | 5.38M | 879.7K | 741.54K | 874.84K | 691.59K | 60.11K | 42.6K | 9.79K | 3.65K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 251.89K | 444.67K | 467.8K | 1.3M | 759.52K | 42.84K | 337K | 269.08K | 627.43K | 594.8K | 804.02K | 203.78K | 262.56K | 667.63K | 440.33K | 477.31K | 59.84K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 370.5K | 0 | 0 | 698.6K | 0 | 0 | 0 |
| Operating Income | 0 | -1.76M | -1.04M | -2.13M | -1.15M | -5.07M | -2.19M | -2.91M | -6.01M | -1.47M | -1.92M | -1.08M | -954.15K | -1.43M | -482.94K | -487.1K | -63.49K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 100% | 65.19% | 52.4% | 26.53% | 80.91% | -243.84% | -14.18% | -169.37% | -529.48% | -3.38% | -296.75% | -121.44% | - | - | -660.65% | - | - |
| EBITDA | 0 | -1.72M | -989.69K | -2.06M | -1.1M | -5.07M | -2.18M | -2.9M | -5.99M | 0 | 0 | -8.57M | -954.15K | -1.43M | 0 | 0 | -63.49K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 100% | 66.09% | 54.6% | 28.84% | 81.65% | - | - | 66.16% | -527.86% | 100% | - | - | - | - | 100% | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.47M | 1.92M | 0 | 0 | 0 | 482.94K | 487.1K | 0 |
| EBIT | 0 | -1.72M | -989.69K | -2.06M | -1.1M | -5.07M | -2.18M | -2.9M | -5.99M | -1.45M | -1.92M | -8.57M | -954.15K | -1.43M | -482.94K | -487.1K | -63.49K |
| Net Interest Income | 0 | 43.15K | 50.39K | 72.1K | 41.5K | 20 | 0 | 7.06K | 15.45K | 25.49K | -4.34M | -761.82K | -757.17K | -124.05K | 0 | 0 | 0 |
| Interest Income | 41.88K | 46.18K | 51.64K | 72.1K | 44.23K | 1.36K | 0 | 7.06K | 15.45K | 25.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -1.91K | 3.03K | 1.25K | 0 | 2.73K | 1.34K | 0 | 0 | 0 | 0 | 4.34M | 761.82K | 757.17K | 124.05K | 0 | 0 | 0 |
| Other Income/Expense | 0 | 43.15K | 50.39K | 73.49K | 44.18K | 20 | 7.95K | 7.06K | 15.45K | 25.49K | -4.34M | -8.25M | -757.17K | -124.05K | 0 | 0 | 0 |
| Pretax Income | -705.23K | -1.72M | -990.95K | -2.06M | -1.1M | -5.07M | -2.18M | -2.9M | -5.99M | -1.45M | -6.25M | -9.33M | -1.71M | -1.55M | -482.94K | -487.1K | -63.49K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -705.23K | -1.72M | -990.95K | -2.06M | -1.1M | -5.07M | -2.18M | -2.9M | -5.99M | -1.45M | -6.25M | -9.33M | -1.71M | -1.55M | -482.94K | -487.1K | -63.49K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 36.02% | 66.04% | 54.54% | 28.88% | 81.6% | -249.89% | 65.15% | 68.93% | -250.06% | 6.54% | -1195.12% | -1814.86% | - | - | -660.65% | - | - |
| Net Income (Continuing) | -705.23K | -1.72M | -990.95K | -2.06M | -1.1M | -5.07M | -2.18M | -2.9M | -5.99M | -1.45M | -6.25M | -9.33M | -1.71M | -1.55M | -482.94K | -487.1K | -63.49K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.01 | -1.39 | -0.03 | -0.06 | -0.03 | -0.17 | -0.07 | -0.10 | -0.20 | -0.05 | -0.23 | -0.32 | -0.06 | -0.05 | -0.02 | -0.02 | -0.00 |
| EPS Growth % | 70.59% | -717.65% | 59.02% | 38.78% | 83% | -247.65% | 68.17% | 69.38% | -246.02% | 6.68% | -1311.04% | -1839.39% | - | - | - | - | - |
| EPS (Basic) | -0.01 | -1.39 | -0.03 | -0.06 | -0.03 | -0.17 | -0.07 | -0.10 | -0.20 | -0.05 | -0.23 | -0.32 | -0.06 | -0.05 | -0.02 | -0.02 | -0.00 |
| Diluted Shares Outstanding | 68.77M | 34.38M | 34.38M | 34.38M | 31.04M | 30.01M | 29.76M | 29.54M | 29.61M | 29.61M | 29.28M | 29.61M | 29.61M | 29.61M | 29.61M | 29.61M | 29.61M |
| Basic Shares Outstanding | 68.77M | 34.38M | 34.38M | 34.38M | 31.04M | 30.01M | 29.76M | 29.54M | 29.61M | 29.61M | 29.28M | 29.61M | 29.61M | 29.61M | 29.61M | 29.61M | 29.61M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |